The innovative drug concept is repeatedly active, and Staidson BioPharm has reached a new historical high
36Kr learned that as of the time of publication, the innovative drug concept has been repeatedly active, Staidson BioPharm has reached a new historical high, Thalys has had two consecutive limit-ups, Chipscreen has risen over 10%, and ALK, GZBL, and huahaipharm have seen significant increases
Source: 36Kr The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments